Apogee Net Debt from 2010 to 2025
| APGE Stock | 42.50 2.18 5.41% |
Net Debt | First Reported 2010-12-31 | Previous Quarter -133.7 M | Current Value -140.4 M | Quarterly Volatility 9.9 M |
Check Apogee Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apogee Therapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 10.9 M, Interest Income of 10.9 M or Depreciation And Amortization of 7.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.52. Apogee financial statements analysis is a perfect complement when working with Apogee Therapeutics, Valuation or Volatility modules.
Apogee |
Latest Apogee Therapeutics,'s Net Debt Growth Pattern
Below is the plot of the Net Debt of Apogee Therapeutics, Common over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Apogee Therapeutics,'s Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apogee Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Apogee Net Debt Regression Statistics
| Arithmetic Mean | (147,811,676) | |
| Geometric Mean | 147,464,545 | |
| Coefficient Of Variation | (6.68) | |
| Mean Deviation | 6,627,277 | |
| Median | (151,890,000) | |
| Standard Deviation | 9,877,845 | |
| Sample Variance | 97.6T | |
| Range | 35.6M | |
| R-Value | 0.57 | |
| Mean Square Error | 70.9T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 1,176,521 | |
| Total Sum of Squares | 1463.6T |
Apogee Net Debt History
Other Fundumenentals of Apogee Therapeutics,
Apogee Therapeutics, Net Debt component correlations
Click cells to compare fundamentals
About Apogee Therapeutics, Financial Statements
Apogee Therapeutics, stakeholders use historical fundamental indicators, such as Apogee Therapeutics,'s Net Debt, to determine how well the company is positioned to perform in the future. Although Apogee Therapeutics, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Apogee Therapeutics,'s assets and liabilities are reflected in the revenues and expenses on Apogee Therapeutics,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Apogee Therapeutics, Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt | -133.7 M | -140.4 M | |
| Net Debt To EBITDA | 1.25 | 1.10 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Apogee Therapeutics, is a strong investment it is important to analyze Apogee Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apogee Therapeutics,'s future performance. For an informed investment choice regarding Apogee Stock, refer to the following important reports:Check out the analysis of Apogee Therapeutics, Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apogee Therapeutics,. If investors know Apogee will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apogee Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Apogee Therapeutics, is measured differently than its book value, which is the value of Apogee that is recorded on the company's balance sheet. Investors also form their own opinion of Apogee Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Apogee Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apogee Therapeutics,'s market value can be influenced by many factors that don't directly affect Apogee Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apogee Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Apogee Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apogee Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.